Published in Pharma Law Weekly, November 22nd, 2005
Results from the study demonstrated that the group of patients (n=3D20) treated with Lidoderm (lidocaine patch 5%), applied to the painful wrist region achieved a 41.5% reduction in mean pain intensity as measured by the brief pain inventory (BPI) at week 0 (5.3/10 score) and at week 4 (3.1/10 score). In the group (n=3D20) given a single corticosteroid injection into the carpal tunnel, patients achieved a 43.8%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.